Bilimsel çalışmalar

Doç. Dr. Merih Reis Aras

65 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön
  1. Transfüzyon Reaksiyonlarının Değerlendirilmesi; Bir Şehir Hastanesi Deneyimi

    OSMANGAZİ JOURNAL OF MEDICINE, 2026

    DOI 10.20515/otd.1884703 Açık erişimli tam metinKaynak: ORCID

  2. Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL

    Annals of Hematology, 2026

    DOI 10.1007/s00277-026-07201-y PMID 42897372 Açık erişimli tam metinKaynak: ORCID

  3. An investigation of the predictive markers that can be used in thedifferentiation of benign and malignant lymphadenopathy

    Annals of Clinical and Analytical Medicine, 2025

    DOI 10.4328/acam.22536 Kaynak: ORCID

  4. Potential effects of liver dysfunction at the time of diagnosis in patients with acute myeloid leukemia

    Experimental and Therapeutic Medicine, 2025

    DOI 10.3892/etm.2025.12795 PMID 39817155 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  5. Mean platelet volume and platelet distribution width in the prediction of treatment response in immune thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a multicenter study

    Gulhane Medical Journal, 2024

    DOI 10.4274/gulhane.galenos.2023.85520 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  6. Novel mutated Dubin–Johnson syndrome diagnosed during acute promyelocytic leukemia treatment

    memo - Magazine of European Medical Oncology, 2024

    DOI 10.1007/s12254-024-00982-w Kaynak: OpenAlex

  7. The Charlson Comorbidity Index Predicts Poor Prognosis in Elderly AML Patients

    AYBU AVESIS, 2023

    DOI 10.4999/uhod.236829 Kaynak: OpenAlex

  8. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.66742 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  9. Comparison of maintenance regimens in Acute Promyelocytic Leukemia patients

    Leukemia research, 2023

    DOI 10.1016/j.leukres.2023.107055 PMID 36893697 1 atıf (Europe PMC) Kaynak: ORCID

  10. Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?

    Hitit Medical Journal, 2023

    DOI 10.52827/hititmedj.1301431 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID

  11. In the management of febrile neutropenia; evaluation of the factors affecting the lenght of hospital stay

    Turkish Journal of Clinics and Laboratory, 2023

    DOI 10.18663/tjcl.1342134 Açık erişimli tam metinKaynak: OpenAlex

  12. A Very Rare Cause of Bicytopenia; The Use of Vitex Acnu Castus

    Academic Journal of Health, 2023

    DOI 10.14744/ajh.2023.76486 Kaynak: OpenAlex

  13. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study

    Journal of Hematopathology, 2022

    DOI 10.1007/s12308-022-00523-6 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  14. Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

    Journal of Hematopathology, 2022

    DOI 10.1007/s12308-022-00488-6 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  15. A rare case of pulmonary lymphomatoid granulomatosis complicated with venous thrombosis.

    Sarcoidosis vasculitis and diffuse lung diseases, 2022

    DOI 10.36141/svdld.v38i4.10140 PMID 35115745 Açık erişimli tam metinKaynak: OpenAlex

  16. The impact of hematological parameters on survival for patients with COVID-19

    Ahi Evran Medical Journal, 2022

    DOI 10.46332/aemj.1014259 Açık erişimli tam metinKaynak: OpenAlex

  17. Analysis of Demographic and Disease Characteristics of Patients with Chronic Myeloid Leukemia: A Single Centre Retrospective Analysis

    Acta Oncologica Turcica, 2022

    DOI 10.5505/aot.2022.08831 Açık erişimli tam metinKaynak: OpenAlex

  18. Does blood type have an effect on the course of COVID-19?

    Sağlık Akademisi Kastamonu, 2022

    DOI 10.25279/sak.1014330 Açık erişimli tam metinKaynak: OpenAlex

  19. Single Centre Experience: Bening and Malign Hematological Patients with COVID-19

    Sağlık Akademisi Kastamonu, 2022

    DOI 10.25279/sak.1061701 Açık erişimli tam metinKaynak: OpenAlex

  20. Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect

    Journal of Clinical Pharmacy and Therapeutics, 2022

    DOI 10.1111/jcpt.13512 PMID 34423448 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  21. Effect of Blood Groups on Clinical Presentations and Treatment Outcomes in Immune Thrombotic Thrombocytopenic Purpura Patients with Severe ADAMTS13 Deficiency: A Multi-Center Experience

    Transfusion Medicine and Hemotherapy, 2022

    DOI 10.1159/000524597 PMID 36818771 7 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  22. Analysis of factors predicting the efficacy of Imatinib in patients with Chronic Myeloid Leukemia: A retrospective analysis

    Medical Science and Discovery, 2022

    DOI 10.36472/msd.v9i9.802 Açık erişimli tam metinKaynak: OpenAlex

  23. THE RELATIONSHIP BETWEEN FERRITIN LEVEL AND THROMBOSIS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

    Hematology Transfusion and Cell Therapy, 2022

    DOI 10.1016/j.htct.2022.09.1244 Açık erişimli tam metinKaynak: OpenAlex

  24. Endokrin Sistem Tümörleri

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.353 Kaynak: OpenAlex

  25. The outcome of COVID-19 in patients with hematological malignancy

    memo - Magazine of European Medical Oncology, 2021

    DOI 10.1007/s12254-021-00775-5 PMID 34904019 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  26. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211007889 PMID 33847196 6 atıf (Europe PMC) Kaynak: OpenAlex

  27. Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment

    Journal of Oncology Pharmacy Practice, 2021

    DOI 10.1177/10781552211060730 PMID 34775854 3 atıf (Europe PMC) Kaynak: OpenAlex

  28. RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1057 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  29. A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1033 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  30. CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1039 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  31. A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1034 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  32. Analysis of demographic and clinical characteristics of primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis patients

    Gulhane Medical Journal, 2021

    DOI 10.4274/gulhane.galenos.2020.1243 Açık erişimli tam metinKaynak: OpenAlex

  33. A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1045 Açık erişimli tam metinKaynak: OpenAlex

  34. IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.973 Açık erişimli tam metinKaynak: OpenAlex

  35. CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1030 Açık erişimli tam metinKaynak: OpenAlex

  36. A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1064 Açık erişimli tam metinKaynak: OpenAlex

  37. THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.979 Açık erişimli tam metinKaynak: OpenAlex

  38. T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1019 Açık erişimli tam metinKaynak: OpenAlex

  39. A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1060 Açık erişimli tam metinKaynak: OpenAlex

  40. Disease and Clinical Characteristics of Patients with Chronic Myeloproliferative Neoplasms: 11-year single center experience

    Acta Oncologica Turcica, 2021

    DOI 10.5505/aot.2021.93357 Açık erişimli tam metinKaynak: OpenAlex

  41. INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1018 Açık erişimli tam metinKaynak: OpenAlex

  42. A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1037 Açık erişimli tam metinKaynak: OpenAlex

  43. DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1056 Açık erişimli tam metinKaynak: OpenAlex

  44. The predictive value of FDG-PET / CT in assessing bone marrow involvement in Hodgkin Lymphoma patients; A single center experience

    Acta Oncologica Turcica, 2021

    DOI 10.5505/aot.2021.08941 Açık erişimli tam metinKaynak: OpenAlex

  45. Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey.

    PubMed, 2021

    PMID 34565016 Açık erişimli tam metinKaynak: OpenAlex

  46. Pralatrexate experience in peripheral T-cell lymphoma: A multicenter retrospective study from Turkey

    AYBU AVESIS, 2021

    Kaynak: OpenAlex

  47. Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis

    Leukemia & lymphoma/Leukemia and lymphoma, 2021

    DOI 10.1080/10428194.2021.1929962 PMID 34013848 4 atıf (OpenAlex) Kaynak: OpenAlex

  48. THERAPEUTIC PLASMA EXCHANGE IN PATIENTS WITH NEUROLOGICAL DISEASES: A 9-YEAR, SINGLE-CENTER EXPERIENCE

    Hematology Transfusion and Cell Therapy, 2021

    DOI 10.1016/j.htct.2021.10.1055 Açık erişimli tam metinKaynak: OpenAlex

  49. The importance of tyrosine kinase-like orphan receptor 1 (Ror-1) in chronic lymphocytic leukemia

    AYBU AVESIS, 2021

    DOI 10.4999/uhod.215209 Kaynak: OpenAlex

  50. The prognostic impact of comorbidity, nutritional and performance status on patients with diffuse large B cell lymphoma

    Hematology Transfusion and Cell Therapy, 2020

    DOI 10.1016/j.htct.2020.09.040 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex